ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch instituteEpalingesHedera Dx Life Sciences SA
Hedera Dx Life Sciences SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Hedera Dx Life Sciences SA develops next-generation sequencing (NGS) solutions for molecular cancer testing. Its activities include tumor profiling using tissue and liquid biopsies, software for analysis and reporting, and oncology studies and real-world evidence services.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Research instituteMedical laboratory
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.6/5

Hedera Dx Life Sciences SA

✓ Offered5
Tumor Profiling Panels (Hedera Profiling)
NGS panels for tumor profiling using tissue samples and ctDNA; depending on the panel, they detect SNVs, indels, copy-number variations, fusions and microsatellite instability.
NGS Sequencing Services
NGS-based tumor profiling and monitoring using tissue and liquid biopsies, including translational research programs, clinical trials and biomarker-driven patient stratification.
NGS Analysis and Reporting Software (Hedera Prime)
Software for somatic variant assessment and customizable clinical reporting, with ranked therapy options linked to regulatory-approved medicines.
Laboratory Implementation and IVDR Validation Support
Support for integrating liquid biopsy testing into laboratory workflows, including onsite training, hands-on laboratory instruction, run assessment, software training, and validation and documentation assistance.
Prospective Real-World Evidence Studies in Oncology
Design and operation of prospective oncology studies using longitudinal clinical and molecular data and patient-reported outcomes; study design, patient selection, biomarker panels and endpoints can be tailored.
Trust & reputation

ranQ Trust Score of Hedera Dx Life Sciences SA: 3.6 out of 5.0

Trust Score3.6/ 5.0

Solid

x

Data basis 58% · As of November 2026

Hedera Dx Life Sciences SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Hedera Dx Life Sciences SA scores 42.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Hedera Dx Life Sciences SA scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Hedera Dx Life Sciences SA scores 46.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.16.74%
Qualifications+0.00

Hedera Dx Life Sciences SA reaches a ranQ Trust Score of 3.6 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 27, 2025Media
Hedera Dx raises €15M to bring modern cancer care to patients worldwide
startupticker.ch

Knowledge

No knowledge articles yet

Once Hedera Dx Life Sciences SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Hedera Dx Life Sciences SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Hedera Dx Life Sciences SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Hedera Dx Life Sciences SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 5
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-407.676.790
Founded
2026 · 0 years
Last commercial register change
November 12, 2026
Employees
1 to 10

Active in 1 of 26 cantons · 1 municipality

  • VDEpalinges
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    HD
    Hedera Dx SA
    Epalinges
    AB
    Adaptyv Biosystems Sàrl
    Epalinges
    SB
    Swiss Biotech Laboratories Europe Sàrl
    Epalinges
    VS
    VivoArchitect Sàrl
    Epalinges
    OD
    OCULIGHT dynamics Sàrl
    Epalinges
    TB
    TwinEdge Bioscience SA
    Epalinges
    IM
    Institut Mémoire & Justice
    Aubonne
    PS
    PMO4Med Sàrl
    Bassins